Experiment 1055585
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | TAYLOR,S: BELT,RJ: HAAS,CD: HOOGSTRATEN,B:. (1983). PHASE I TRIAL OF INDICINE-N-OXIDE ON TWO DOSE SCHEDULES.. 51(11) |
| Amount utilized | |
| Compound isolated | |
| Disease | A PHASE I CLINICAL TRIAL OF THE TITLE COMPOUND IN 29 PATIENTS. DOSE RANGE WAS 1.0-7.5 GM/SQ.M. PER WEEK. 15 OF 40 OF THE COURSES OF 4 DOSES WERE INTERUPTED BY MYELOSUPPRESSION WHICH PROHIBITED COMPLETION OF THE COURSE. |
| Dose amount | 7.5 GM |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |